These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35398142)

  • 21. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
    Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
    Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.
    Zhang RX; Zhang M; Li A; Pan L; Berman BM; Ren K; Lao L
    Neuroscience; 2013 Nov; 252():359-66. PubMed ID: 23994597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
    Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
    Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
    Kanarek RB; Mandillo S; Wiatr C
    Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
    Datta U; Kelley LK; Middleton JW; Gilpin NW
    Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of opioidergic system in modulating cost/benefit decision-making in alcohol-preferring AA rats and Wistar rats.
    Oinio V; Sundström M; Bäckström P; Uhari-Väänänen J; Kiianmaa K; Raasmaja A; Piepponen P
    Behav Pharmacol; 2021 Apr; 32(2&3):220-228. PubMed ID: 33229893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid- to late gestational morphine exposure does not alter the rewarding properties of morphine in adult male rats.
    Riley MA; Vathy I
    Neuropharmacology; 2006 Aug; 51(2):295-304. PubMed ID: 16697425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in morphine reward in a model of neuropathic pain.
    Cahill CM; Xue L; Grenier P; Magnussen C; Lecour S; Olmstead MC
    Behav Pharmacol; 2013 Jun; 24(3):207-13. PubMed ID: 23591124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.
    Hou YY; Cai YQ; Pan ZZ
    Neuroscience; 2020 Feb; 426():141-153. PubMed ID: 31863796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.
    Araldi D; Bogen O; Green PG; Levine JD
    J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D1- and D2-like receptors in the dentate gyrus region of the hippocampus are involved in the reinstatement induced by a subthreshold dose of morphine and forced swim stress in extinguished morphine-CPP in rats.
    Norozpour Y; Zarrabian S; Rezaee L; Haghparast A
    Behav Neurosci; 2019 Dec; 133(6):545-555. PubMed ID: 31414832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frustrative nonreward: Detailed c-Fos expression patterns in the amygdala after consummatory successive negative contrast.
    Arjol D; Agüera ADR; Hagen C; Papini MR
    Neurobiol Learn Mem; 2024 Sep; 213():107942. PubMed ID: 38815677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure.
    Sahbaie P; Liang DY; Shi XY; Sun Y; Clark JD
    Mol Pain; 2016; 12():. PubMed ID: 27094549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance to morphine-induced antinociception is decreased by chronic sucrose or polycose intake.
    D'Anci KE
    Pharmacol Biochem Behav; 1999 May; 63(1):1-11. PubMed ID: 10340517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use.
    Berger AC; Whistler JL
    EMBO Mol Med; 2011 Jul; 3(7):385-97. PubMed ID: 21656686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Context-specific morphine tolerance on the paw-pressure and tail-shock vocalization tests: evidence of associative tolerance without conditioned compensatory responding.
    Cepeda-Benito A; Tiffany ST; Cox LS
    Psychopharmacology (Berl); 1999 Aug; 145(4):426-32. PubMed ID: 10460320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine.
    Zadina JE; Nilges MR; Morgenweck J; Zhang X; Hackler L; Fasold MB
    Neuropharmacology; 2016 Jun; 105():215-227. PubMed ID: 26748051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward.
    Bie B; Wang Y; Cai YQ; Zhang Z; Hou YY; Pan ZZ
    Neuropsychopharmacology; 2012 Dec; 37(13):2780-8. PubMed ID: 22871918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine and ethanol pretreatment effects on expression and extinction of ethanol-induced conditioned place preference and aversion in mice.
    Cunningham CL; Bakner L; Schuette LM; Young EA
    Psychopharmacology (Berl); 2021 Jan; 238(1):55-66. PubMed ID: 32980910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.